Raphas Co. Ltd (214260) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.031x

Based on the latest financial reports, Raphas Co. Ltd (214260) has a cash flow conversion efficiency ratio of 0.031x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩847.42 Million ≈ $574.29K USD) by net assets (₩27.54 Billion ≈ $18.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Raphas Co. Ltd worth for the company's overall valuation and market capitalisation.

Raphas Co. Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Raphas Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Raphas Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Raphas Co. Ltd ranked by their cash flow conversion efficiency. Explore Raphas Co. Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
EstechPharma Co. Ltd
KQ:041910
0.018x
Dongyang Expre
KO:084670
0.059x
Ocumetics Technology Corp
V:OTC
0.022x
Grupo Pochteca S.A.B. de C.V
MX:POCHTECB
-0.210x
Dongwon Metal
KO:018500
0.143x
Ensari Deri Gida Sanayi ve Ticaret AS
IS:ENSRI
0.094x
Econpile Holdings Bhd
KLSE:5253
0.006x
Goodyear (Thailand) Public Company Limited
BK:GYT
0.033x

Annual Cash Flow Conversion Efficiency for Raphas Co. Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Raphas Co. Ltd from 2017 to 2025. View Raphas Co. Ltd stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩30.71 Billion
≈ $20.81 Million
₩1.43 Billion
≈ $970.87K
0.047x -71.96%
2024-12-31 ₩29.36 Billion
≈ $19.90 Million
₩4.88 Billion
≈ $3.31 Million
0.166x +397.25%
2023-12-31 ₩32.31 Billion
≈ $21.89 Million
₩-1.81 Billion
≈ $-1.23 Million
-0.056x +36.98%
2022-12-31 ₩40.93 Billion
≈ $27.74 Million
₩-3.63 Billion
≈ $-2.46 Million
-0.089x -639.31%
2021-12-31 ₩52.36 Billion
≈ $35.48 Million
₩862.01 Million
≈ $584.17K
0.016x -19.52%
2020-12-31 ₩44.18 Billion
≈ $29.94 Million
₩903.85 Million
≈ $612.53K
0.020x +135.31%
2019-12-31 ₩47.83 Billion
≈ $32.42 Million
₩-2.77 Billion
≈ $-1.88 Million
-0.058x -79.15%
2018-12-31 ₩20.13 Billion
≈ $13.64 Million
₩-651.09 Million
≈ $-441.23K
-0.032x +50.53%
2017-12-31 ₩23.74 Billion
≈ $16.09 Million
₩-1.55 Billion
≈ $-1.05 Million
-0.065x --

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology
Market Cap
$42.74 Million
₩63.06 Billion KRW
Market Cap Rank
#22567 Global
#1460 in Korea
Share Price
₩7500.00
Change (1 day)
-1.06%
52-Week Range
₩6720.00 - ₩15350.00
All Time High
₩75400.00
About

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organiza… Read more